Role of Curcumin and Fenofibrate on Cardiovascular Events in Type 2 Diabetes Mellitus.

Document Type : Mini review

Authors

1 Associate Professor of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, Damanhur University, Damanhour 22514, Egypt.

2 Master candidate, Ministry of Health and Population, Damanhour City, Egypt.

3 Associate Professor of Internal Medicine-Diabetes &Endocrinology, Faculty of Medicine, Tanta University, Tanta, Egypt.

4 Professor of Pharmaceutics, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt.

Abstract

Background and aim
Type 2 diabetes mellitus is associated with cardiovascular complications that account for a high percentage of mortality and increase the clinical burden on the healthcare system. Herbal products like curcumin and chemical drugs like fenofibrate were found to be effective in decreasing complications associated with heart in type 2 diabetes. The aim of this study is to evaluate the role of curcumin and fenofibrate on cardiovascular complications in type 2 diabetes in a minireview.
Methods
We reviewed the online databases PubMed, Science Direct, and Google Scholar for articles discussing the impact of curcumin or fenofibrate in improving lipid profile in patients with type 2 diabetes.
Results
The prior studies demonstrated the impact of consuming curcumin or fenofibrate to improve the lipid profile in people with type 2 diabetes. Triglycerides (TG), low-density lipoprotein (LDL), and total cholesterol (TC) were reduced with either curcumin or fenofibrate. In contrast, high-density lipoprotein (HDL) levels were increased.
Conclusions
Curcumin or fenofibrate consumption in patients with type 2 diabetes enhances lipid profile, hence decreasing insulin resistance and reducing cardiovascular complications.

Keywords

Main Subjects

Files

Share

How to cite

Statistics